James Lay‐Flurrie

1.3k total citations
21 papers, 159 citations indexed

About

James Lay‐Flurrie is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, James Lay‐Flurrie has authored 21 papers receiving a total of 159 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 9 papers in Endocrinology, Diabetes and Metabolism and 9 papers in Physiology. Recurrent topics in James Lay‐Flurrie's work include Asthma and respiratory diseases (9 papers), Heart Failure Treatment and Management (8 papers) and Hormonal Regulation and Hypertension (7 papers). James Lay‐Flurrie is often cited by papers focused on Asthma and respiratory diseases (9 papers), Heart Failure Treatment and Management (8 papers) and Hormonal Regulation and Hypertension (7 papers). James Lay‐Flurrie collaborates with scholars based in United Kingdom, United States and Singapore. James Lay‐Flurrie's co-authors include Henrik Svedsäter, David Leather, Scott D. Solomon, Carolyn S.P. Lam, John J.V. McMurray, Prabhakar Viswanathan, Loretta Jacques, Brian Claggett, Faı̈ez Zannad and Pardeep S. Jhund and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and BMC Medical Research Methodology.

In The Last Decade

James Lay‐Flurrie

20 papers receiving 153 citations

Peers

James Lay‐Flurrie

CCM

EDM

PRM

PHYSI

Eugene B. Reyes Philippines

Luise Adam Switzerland

Eva Turgonyi United Kingdom

Bruce M. Psaty United States

Azmee Mohd Ghazi Malaysia

Ricardo García‐Sánchez United States

А. А. Гарганеева Russia

Anne Platts United States

Yuan Shen China

Simone Inkrot Germany

Eugene B. Reyes Philippines

James Lay‐Flurrie

234 ×3.5

CCM

53 ×0.9

EDM

23 ×0.4

PRM

12 ×0.3

PHYSI

9 ×0.6

Citations per year, relative to James Lay‐Flurrie James Lay‐Flurrie (= 1×) peers Eugene B. Reyes

Countries citing papers authored by James Lay‐Flurrie

Since Specialization

Citations

This map shows the geographic impact of James Lay‐Flurrie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Lay‐Flurrie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Lay‐Flurrie more than expected).

Fields of papers citing papers by James Lay‐Flurrie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Lay‐Flurrie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Lay‐Flurrie. The network helps show where James Lay‐Flurrie may publish in the future.

Co-authorship network of co-authors of James Lay‐Flurrie

This figure shows the co-authorship network connecting the top 25 collaborators of James Lay‐Flurrie. A scholar is included among the top collaborators of James Lay‐Flurrie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Lay‐Flurrie. James Lay‐Flurrie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ostrominski, John W., Muthiah Vaduganathan, Brian Claggett, et al.. (2025). Finerenone and NYHA Functional Class in Heart Failure. JACC Heart Failure. 14(1). 102440–102440.

Desai, Akshay S., Pardeep S. Jhund, Muthiah Vaduganathan, et al.. (2025). Mode of Death in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction. JAMA Cardiology. 10(7). 678–678. 1 indexed citations

Cunningham, Jonathan W., Brian Claggett, Muthiah Vaduganathan, et al.. (2025). Effects of Finerenone on Natriuretic Peptide Levels in Heart Failure with Mildly Reduced or Preserved Ejection Fraction: The FINEARTS-HF Trial. European Journal of Heart Failure. 27(8). 1487–1491. 1 indexed citations

Claggett, Brian, Jacob A. Udell, Akshay S. Desai, et al.. (2025). Blinded Withdrawal of Finerenone After Long-Term Treatment in the FINEARTS-HF Trial. Journal of the American College of Cardiology. 86(5). 396–399. 1 indexed citations

Ostrominski, John W., Rahul Aggarwal, Brian Claggett, et al.. (2024). Generalizability of the Spectrum of Kidney Risk in the FINEARTS-HF Trial to U.S. Adults With Heart Failure. Journal of Cardiac Failure. 30(9). 1170–1174. 4 indexed citations

Vaduganathan, Muthiah, Brian Claggett, Ian J. Kulac, et al.. (2024). Effects of the Nonsteroidal MRA Finerenone With and Without Concomitant SGLT2 Inhibitor Use in Heart Failure. Circulation. 151(2). 149–158. 25 indexed citations

Desai, Akshay S., Muthiah Vaduganathan, Brian Claggett, et al.. (2024). Finerenone in Patients With a Recent Worsening Heart Failure Event. Journal of the American College of Cardiology. 85(2). 106–116. 9 indexed citations

Vaduganathan, Muthiah, Brian Claggett, Carolyn S.P. Lam, et al.. (2024). Finerenone in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction: Rationale and Design of the FINEARTS-HF Trial. European Journal of Heart Failure. 26(6). 1324–1333. 30 indexed citations

Vaduganathan, Muthiah, Brian Claggett, Akshay S. Desai, et al.. (2024). Estimated Long-Term Benefits of Finerenone in Heart Failure. JAMA Cardiology. 10(2). 176–176. 5 indexed citations

10.

Ostrominski, John W., Brian Claggett, Zi Michael Miao, et al.. (2024). Cardiovascular-Kidney-Metabolic Overlap in Heart Failure With Mildly Reduced or Preserved Ejection Fraction. Journal of the American College of Cardiology. 84(2). 223–228. 17 indexed citations

11.

Jones, Rupert, Andy Nicholls, Nawar Diar Bakerly, et al.. (2020). Impact of socioeconomic status on participation and outcomes in the Salford Lung Studies. ERJ Open Research. 6(1). 193–2019. 4 indexed citations

12.

Tibble, Holly, James Lay‐Flurrie, Aziz Sheikh, et al.. (2020). Linkage of primary care prescribing records and pharmacy dispensing Records in the Salford Lung Study: application in asthma. BMC Medical Research Methodology. 20(1). 303–303. 7 indexed citations

13.

Kosinski, Mark, Linda Nelsen, Avery A. Rizio, et al.. (2020). Psychometric properties of the Asthma Control Test in 2 randomized clinical trials. The Journal of Allergy and Clinical Immunology In Practice. 9(1). 561–563.e1. 5 indexed citations

14.

Doward, Lynda, Henrik Svedsäter, Diane Whalley, et al.. (2019). A descriptive follow-up interview study assessing patient-centred outcomes: Salford Lung Study in Asthma (SLS Asthma). npj Primary Care Respiratory Medicine. 29(1). 31–31. 1 indexed citations

15.

Whalley, Diane, Henrik Svedsäter, Lynda Doward, et al.. (2019). Follow-up interviews from The Salford Lung Study (COPD) and analyses per treatment and exacerbations. npj Primary Care Respiratory Medicine. 29(1). 20–20. 4 indexed citations

16.

Svedsäter, Henrik, Rupert Jones, Nick Bosanquet, et al.. (2018). Patient-reported outcomes with initiation of fluticasone furoate/vilanterol versus continuing usual care in the Asthma Salford Lung Study. Respiratory Medicine. 141. 198–206. 14 indexed citations

17.

Bakerly, Nawar Diar, et al.. (2018). Healthcare resource utilisation (HRU) in the Asthma Salford Lung Study (SLS asthma). PA5036–PA5036. 2 indexed citations

18.

Woodcock, Ashley, Rupert Jones, Loretta Jacques, et al.. (2018). P39 The salford lung study in asthma: relationship between asthma control test (ACT) control status and future asthma exacerbations. A117.2–A118. 1 indexed citations

19.

Jacques, Loretta, Nawar Diar Bakerly, John P. New, et al.. (2018). Effectiveness of fluticasone furoate/vilanterol versus fluticasone propionate/salmeterol on asthma control in the Salford Lung Study. Journal of Asthma. 56(7). 748–757. 14 indexed citations

20.

Doward, Lynda, Henrik Svedsäter, Diane Whalley, et al.. (2017). Salford Lung Study in chronic obstructive pulmonary disease (SLS COPD): follow-up interviews on patient-centred outcomes. npj Primary Care Respiratory Medicine. 27(1). 66–66. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact